Chairman, President & CEO of Merck & Co Inc (MRK, Financial) Kenneth C Frazier sold 135,613 shares of MRK on 02/19/2019 at an average price of $80.03 a share. The total sale was $10.9 million.
Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Merck & Co Inc has a market cap of $206.05 billion; its shares were traded at around $79.24 with a P/E ratio of 34.16 and P/S ratio of 5.14. The dividend yield of Merck & Co Inc stocks is 2.50%.
CEO Recent Trades:
- Chairman, President & CEO Kenneth C Frazier sold 135,613 shares of MRK stock on 02/19/2019 at the average price of $80.03. The price of the stock has decreased by 0.99% since.
- Chairman, President & CEO Kenneth C Frazier sold 231,566 shares of MRK stock on 02/05/2019 at the average price of $78.08. The price of the stock has increased by 1.49% since.
Directors and Officers Recent Trades:
- Sr. VP Fince-Global Controller Rita A Karachun sold 64,662 shares of MRK stock on 02/14/2019 at the average price of $78.96. The price of the stock has increased by 0.35% since.
- Director Wendell P Weeks sold 5,000 shares of MRK stock on 02/13/2019 at the average price of $78.71. The price of the stock has increased by 0.67% since.
- Exe V-P & Pres. MMD Sanat Chattopadhyay sold 73,727 shares of MRK stock on 02/12/2019 at the average price of $78.62. The price of the stock has increased by 0.79% since.
- Director Leslie A Brun sold 3,052 shares of MRK stock on 02/08/2019 at the average price of $77.22. The price of the stock has increased by 2.62% since.
- Director Thomas H Glocer sold 10,000 shares of MRK stock on 02/04/2019 at the average price of $75.96. The price of the stock has increased by 4.32% since.
For the complete insider trading history of MRK, click here
.
